SCHEMBL24681007

SCHEMBL24681007

COP(O)(=S)OCC1CC(F)C(n2cnc3c(N)ncnc32)O1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 2/20 0.51
▸ ENPP1 P22413 4/20 0.51
▸ P2RY11 Q96G91 2/20 0.51
▸ P2RY1 P47900 4/20 0.49
▸ P2RY2 P41231 3/20 0.49
▸ SRC P12931 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ DNPH1 O43598 1/20 0.49
▸ PRKAB2 O43741 1/20 0.49
▸ TRPM2 O94759 1/20 0.49
▸ LDHA P00338 1/20 0.49
▸ ADRB2 P07550 1/20 0.49
▸ FBP1 P09467 1/20 0.49
▸ ADORA1 P30542 1/20 0.49
▸ PRKAG1 P54619 1/20 0.49
▸ PRKAA2 P54646 1/20 0.49
▸ PDE4D Q08499 1/20 0.49
▸ KCNH2 Q12809 1/20 0.49
▸ PRKAA1 Q13131 1/20 0.49
▸ PDE3A Q14432 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20324638 0.90 P2RY1 (0.52) BCHEENPP1P2RY11P2RY1P2RY2
SCHEMBL20325291 0.90 P2RY1 (0.52) BCHEENPP1P2RY11P2RY1P2RY2
SCHEMBL22571185 0.89 P2RY1 (0.57) BCHEP2RY11P2RY1P2RY2SRC
SCHEMBL20324919 0.86 P2RY1 (0.66) P2RY11P2RY1P2RY2SRCSMN1; SMN2
SCHEMBL21417366 0.86 P2RY1 (0.66) P2RY11P2RY1P2RY2SRCSMN1; SMN2
SCHEMBL20326922 0.86 P2RY1 (0.66) P2RY11P2RY1P2RY2SRCSMN1; SMN2
SCHEMBL20224844 0.86 P2RY1 (0.66) P2RY11P2RY1P2RY2SRCSMN1; SMN2
SCHEMBL22571066 0.86 BCHE (0.54) BCHEENPP1P2RY11P2RY1P2RY2
SCHEMBL22352201 0.85 P2RY1 (0.54) BCHEENPP1P2RY11P2RY1P2RY2
SCHEMBL22571145 0.85 BCHE (0.53) BCHEENPP1P2RY11P2RY1P2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3658565-B1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS BRISTOL MYERS SQUIBB CO (US) 2022-11-09 — — EP disclosed
Send feedback